NEURODEGENERATION THERAPEUTICS INC

EIN: 473789018 501(c)(3)

CHARLOTTESVILLE, VA

Total Revenue
$155,496
Total Expenses
$184,752
Total Assets
$18,565
Net Assets
$13,920
🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Sign In — Free (10 views/day)

Financial Trends

Organization Details

Formation Year
2015
Legal Domicile
VA
Principal Officer
JAMES P BENNETT MD PHD
Phone
4345296457
Tax Period
2018-01-01 to 2018-12-31

NEURODEGENERATION THERAPEUTICS INC, founded in 2015, is a small nonprofit that reported $155K in total revenue in fiscal year 2018. Revenue fell 28% from the prior year — a significant decline worth monitoring. Expenses of $185K exceeded revenue, resulting in a 19% operating deficit.

Mission

CONDUCT BIOMEDICAL RESEARCH

Program Service Accomplishments

Program 1
Expenses: $129,327

DEVELOP A SENSITIVE AND EFFICIENT CELL ASSAY TO DETERMINE THE EFFECTIVENESS OF THERAPIES IN TREATING HUMAN NURAL STEM CELLS FROM NEURODEGENERATIVE DISEASE CASES

Program 2
Expenses: $36,950

ISOLATE AND EXAMINE WITH PCR, THE RNA FROM ABOVE CELLS

Program 3
Expenses: $18,475

BEGIN TO EXAMINE THE RNA AND PROTEINS FROM POST MORTEM CONTROL AND ALZHEIMER'S HUMAN BRAIN

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Sign In — Free (10 views/day)

Financial Overview (2018)

Revenue Breakdown

Contributions & Grants $155,496
Program Service Revenue $0
Investment Income $0
Other Revenue $0
TOTAL REVENUE $155,496

Expense Breakdown

Grants Paid $0
Salaries & Benefits $42,183
Fundraising Expenses $0
Program Expenses $184,752
Other Expenses $142,569
TOTAL EXPENSES $184,752

Year-over-Year Comparison

2018 2017 Change
Revenue $155,496 $216,111 -0.3%
Expenses $184,752 $227,927 -0.2%
Net Income $-29,256 $-11,816 +1.5%
Key Indicators
✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required
🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Sign In

Governance

Voting Members
3
Independent Members
3
Employees
1
Volunteers
3

Governance Policies

✗ Conflict of Interest Policy
✗ Whistleblower Policy
✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School
✗ Operated a Hospital
✗ Provided First Class Travel
✗ Reported Conflict of Interest
✗ Reported Asset Diversion
✗ Excess Benefit Transaction
✗ Made Political Expenditures
✗ Engaged in Lobbying
✗ Operated Donor Advised Fund
✗ Maintained Art Collections
✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers
3
$36,090
Total Directors
3
$36,090
Key Employees
0
$0
Highest Compensated
0
reported
Name Title Hours/Week Role Reportable Comp Other Comp Total
PAULA M KEENEY TREASURER 40.00
Officer Director
$36,090 $0 $36,090
JAMES P BENNETT MD PHD PRESIDENT/DI 40.00
Officer Director
$0 $0 $0
DONNA BENNETT SECRETARY 40.00
Officer Director
$0 $0 $0
Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year Revenue Expenses Assets Net Income
2018 $155,496 $184,752 $18,565 $-29,256
Explore More Nonprofits
→Top 100 Nonprofits in Virginia →Largest U.S. Nonprofits →Best Rated Nonprofits →Most Efficient Nonprofits

Compare NEURODEGENERATION THERAPEUTICS INC with other nonprofits in Virginia and across the country.

We Value Your Privacy
We use cookies and similar technologies to analyze site traffic and improve your experience. By clicking "Accept All", you consent to our use of cookies for analytics and measurement.